Skip to content

Long-term CD4 cell gains on treatment weaker in over-50s

First-line treatment for HIV-2: superior outcomes seen with a boosted protease inhibitor

Elevated CD8 cell count associated with HIV treatment failure

US research shows importance of healthy vitamin D levels for patients with HIV

No superinfections among HIV-positive gay men in Amsterdam reporting risky sex

Gene associated with increased risk of cirrhosis for HIV/HCV-co-infected patients

US approval for hepatitis C drug telaprevir

European approval recommended for hepatitis C drug boceprevir

Rilpivirine (Edurant) approved in United States